TP53 structural variants in metastatic prostatic carcinoma

Sequencing data have been instrumental in identifying oncogenic drivers in prostatic carcinoma and highlighting biomarkers that define aggressive disease. A review of a series of 30 primary and metastatic prostatic carcinomas clinically sequenced at our cancer genomics laboratory utilizing a targete...

Descripción completa

Detalles Bibliográficos
Autores principales: Sirohi, Deepika, Devine, Patrick, Grenert, James P., van Ziffle, Jessica, Simko, Jeffry P., Stohr, Bradley A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583940/
https://www.ncbi.nlm.nih.gov/pubmed/31216325
http://dx.doi.org/10.1371/journal.pone.0218618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583940/
https://www.ncbi.nlm.nih.gov/pubmed/31216325
http://dx.doi.org/10.1371/journal.pone.0218618

Ejemplares similares